<ul>
<li>3 只潜力巨大的低于 20 美元的股票</li>
</ul>
<p>Bioceres Crop Solutions Corp.（NASDAQ:BIOX - 免费报告）- Brookline Capital Management 的投资分析师在 9 月 9 日（星期二）发布的研究报告中下调了 Bioceres Crop Solutions 的 2026 财年每股收益预期。Brookline Capital Management 的分析师 K. Dolliver 现在预计该公司将在本年度发布每股收益为（$0.12），低于之前的预期$0.21。Brookline Capital Management 目前对该股票的评级为 “持有”。市场普遍预计 Bioceres Crop Solutions 当前全年的每股收益为（$0.05）。</p>
<p>其他几位股票分析师最近也对 BIOX 发布了报告。华尔街 Zen 在 8 月 31 日（星期日）的一份报告中将 Bioceres Crop Solutions 的评级从 “卖出” 上调至 “持有”。Canaccord Genuity Group 重申了 “持有” 评级，并在周三对 Bioceres Crop Solutions 的股票发布了$2.50 的目标价（之前为$6.50）。Lake Street Capital 在周三的研究报告中将 Bioceres Crop Solutions 的目标价从$8.00 下调至$5.00，并对该公司给予了 “买入” 评级。最后，Oppenheimer 在周二的研究报告中对 Bioceres Crop Solutions 的股票设定了$5.00 的目标价。两位研究分析师对该股票给予了 “买入” 评级，两位则给予了 “持有” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，共识目标价为$4.17。</p>
<p><strong>获取我们关于 BIOX 的最新报告</strong></p>
<h2>Bioceres Crop Solutions 价格表现</h2>
<p>BIOX 的股票在周五开盘价为$2.09。Bioceres Crop Solutions 的 12 个月低点为$1.97，12 个月高点为$8.93。该公司的债务与股本比率为 0.22，流动比率为 1.02，速动比率为 0.74。该股票的 50 日移动平均价格为$3.32，200 日移动平均价格为$4.10。该公司的市值为$1.3106 亿，市盈率为-2.58，PEG 比率为 0.88，贝塔值为 0.43。</p>
<h2>机构投资者对 Bioceres Crop Solutions 的看法</h2>
<p>机构投资者最近买入和卖出了该股票的股份。Jones Financial Companies Lllp 在第一季度将其在 Bioceres Crop Solutions 的持仓增加了 3535.8%。Jones Financial Companies Lllp 现在拥有 5,490 股该公司的股票，价值$25,000，此前在上个季度又购买了 5,339 股。美国银行在第四季度将其在 Bioceres Crop Solutions 的持仓增加了 186.8%。美国银行现在拥有 5,735 股该公司的股票，价值$35,000，此前在上个季度又购买了 3,735 股。Northern Trust Corp 在第四季度收购了 Bioceres Crop Solutions 的新股份，价值约$93,000。Avanza Fonder AB 在第一季度购买了 Bioceres Crop Solutions 的新股份，价值约$72,000。最后，PDT Partners LLC 在第一季度购买了 Bioceres Crop Solutions 的新股份，价值约$81,000。机构投资者和对冲基金持有该公司 17.68% 的股份。</p>
<h2>关于 Bioceres Crop Solutions</h2>
<p>（获取免费报告）</p>
<p>Bioceres Crop Solutions Corp 及其子公司提供作物生产力解决方案。它通过种子和综合产品、作物保护和作物营养三个部门运营。种子和综合产品部门提供种子特性、种质和种子处理包，以促进更健康和更高产的作物。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票，胜过 Bioceres Crop Solutions</li>
<li>如何最有效地使用 MarketBeat 收益筛选器</li>
<li>接近阻力的高飞股票：3 只值得关注的股票</li>
<li>如何投资蓝筹股</li>
<li>希捷科技引领标准普尔 500：其 120% 涨幅背后的原因是什么？</li>
<li>股票平均计算器</li>
<li>先锋集团的 VUG ETF：您投资组合的终极增长 ETF</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QklPWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QklPWA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>您现在应该投资$1,000 于 Bioceres Crop Solutions 吗？</h2>
<p>在您考虑 Bioceres Crop Solutions 之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Bioceres Crop Solutions 并不在名单上。</p>
<p>虽然 Bioceres Crop Solutions 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

BIOX

<p>布鲁克林资本管理公司的投资分析师已将 Bioceres Crop Solutions Corp.（NASDAQ:BIOX）2026 财年的每股收益预期从 0.21 美元下调至-0.12 美元。该公司对该股票维持 “持有” 评级。其他分析师也调整了他们的评级，加拿大和丰银行将其目标价从 6.50 美元下调至 2.50 美元，而湖街资本设定的目标价为 5.00 美元。目前，该股票的共识评级为 “适度买入”，目标价为 4.17 美元</p>

<ul>
<li>3 Bargain Stocks Under $20 With Major Growth Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>3 只潜力巨大的低于 20 美元的股票</li>
</ul>
</div><p>Bioceres Crop Solutions Corp. (NASDAQ:BIOX - Free Report) - Investment analysts at Brookline Capital Management lowered their FY2026 earnings per share estimates for shares of Bioceres Crop Solutions in a research report issued on Tuesday, September 9th. Brookline Capital Management analyst K. Dolliver now expects that the company will post earnings per share of ($0.12) for the year, down from their previous estimate of $0.21. Brookline Capital Management currently has a &#34;Hold&#34; rating on the stock. The consensus estimate for Bioceres Crop Solutions' current full-year earnings is ($0.05) per share.</p>
<div class="lb-trans"><p>Bioceres Crop Solutions Corp.（NASDAQ:BIOX - 免费报告）- Brookline Capital Management 的投资分析师在 9 月 9 日（星期二）发布的研究报告中下调了 Bioceres Crop Solutions 的 2026 财年每股收益预期。Brookline Capital Management 的分析师 K. Dolliver 现在预计该公司将在本年度发布每股收益为（$0.12），低于之前的预期$0.21。Brookline Capital Management 目前对该股票的评级为 “持有”。市场普遍预计 Bioceres Crop Solutions 当前全年的每股收益为（$0.05）。</p>
</div><p>Several other equities analysts also recently issued reports on BIOX. Wall Street Zen raised shares of Bioceres Crop Solutions from a &#34;sell&#34; rating to a &#34;hold&#34; rating in a report on Sunday, August 31st. Canaccord Genuity Group reaffirmed a &#34;hold&#34; rating and issued a $2.50 price objective (down previously from $6.50) on shares of Bioceres Crop Solutions in a report on Wednesday. Lake Street Capital reduced their target price on shares of Bioceres Crop Solutions from $8.00 to $5.00 and set a &#34;buy&#34; rating for the company in a research note on Wednesday. Finally, Oppenheimer set a $5.00 target price on shares of Bioceres Crop Solutions in a research report on Tuesday. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $4.17.</p>
<div class="lb-trans"><p>其他几位股票分析师最近也对 BIOX 发布了报告。华尔街 Zen 在 8 月 31 日（星期日）的一份报告中将 Bioceres Crop Solutions 的评级从 “卖出” 上调至 “持有”。Canaccord Genuity Group 重申了 “持有” 评级，并在周三对 Bioceres Crop Solutions 的股票发布了$2.50 的目标价（之前为$6.50）。Lake Street Capital 在周三的研究报告中将 Bioceres Crop Solutions 的目标价从$8.00 下调至$5.00，并对该公司给予了 “买入” 评级。最后，Oppenheimer 在周二的研究报告中对 Bioceres Crop Solutions 的股票设定了$5.00 的目标价。两位研究分析师对该股票给予了 “买入” 评级，两位则给予了 “持有” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，共识目标价为$4.17。</p>
</div><p><strong>Get Our Latest Report on BIOX</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 BIOX 的最新报告</strong></p>
</div><h2>Bioceres Crop Solutions Price Performance</h2>
<div class="lb-trans"><h2>Bioceres Crop Solutions 价格表现</h2>
</div><p>Shares of BIOX opened at $2.09 on Friday. Bioceres Crop Solutions has a 12 month low of $1.97 and a 12 month high of $8.93. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.02 and a quick ratio of 0.74. The stock has a fifty day moving average price of $3.32 and a 200 day moving average price of $4.10. The company has a market cap of $131.06 million, a P/E ratio of -2.58, a PEG ratio of 0.88 and a beta of 0.43.</p>
<div class="lb-trans"><p>BIOX 的股票在周五开盘价为$2.09。Bioceres Crop Solutions 的 12 个月低点为$1.97，12 个月高点为$8.93。该公司的债务与股本比率为 0.22，流动比率为 1.02，速动比率为 0.74。该股票的 50 日移动平均价格为$3.32，200 日移动平均价格为$4.10。该公司的市值为$1.3106 亿，市盈率为-2.58，PEG 比率为 0.88，贝塔值为 0.43。</p>
</div><h2>Institutional Investors Weigh In On Bioceres Crop Solutions</h2>
<div class="lb-trans"><h2>机构投资者对 Bioceres Crop Solutions 的看法</h2>
</div><p>Institutional investors have recently bought and sold shares of the stock. Jones Financial Companies Lllp grew its position in Bioceres Crop Solutions by 3,535.8% in the 1st quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company's stock valued at $25,000 after buying an additional 5,339 shares in the last quarter. Bank of America Corp DE raised its position in shares of Bioceres Crop Solutions by 186.8% during the 4th quarter. Bank of America Corp DE now owns 5,735 shares of the company's stock worth $35,000 after buying an additional 3,735 shares in the last quarter. Northern Trust Corp acquired a new stake in shares of Bioceres Crop Solutions in the 4th quarter worth approximately $93,000. Avanza Fonder AB bought a new position in shares of Bioceres Crop Solutions in the first quarter valued at approximately $72,000. Finally, PDT Partners LLC bought a new position in shares of Bioceres Crop Solutions in the first quarter valued at approximately $81,000. Institutional investors and hedge funds own 17.68% of the company's stock.</p>
<div class="lb-trans"><p>机构投资者最近买入和卖出了该股票的股份。Jones Financial Companies Lllp 在第一季度将其在 Bioceres Crop Solutions 的持仓增加了 3535.8%。Jones Financial Companies Lllp 现在拥有 5,490 股该公司的股票，价值$25,000，此前在上个季度又购买了 5,339 股。美国银行在第四季度将其在 Bioceres Crop Solutions 的持仓增加了 186.8%。美国银行现在拥有 5,735 股该公司的股票，价值$35,000，此前在上个季度又购买了 3,735 股。Northern Trust Corp 在第四季度收购了 Bioceres Crop Solutions 的新股份，价值约$93,000。Avanza Fonder AB 在第一季度购买了 Bioceres Crop Solutions 的新股份，价值约$72,000。最后，PDT Partners LLC 在第一季度购买了 Bioceres Crop Solutions 的新股份，价值约$81,000。机构投资者和对冲基金持有该公司 17.68% 的股份。</p>
</div><h2>About Bioceres Crop Solutions</h2>
<div class="lb-trans"><h2>关于 Bioceres Crop Solutions</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.</p>
<div class="lb-trans"><p>Bioceres Crop Solutions Corp 及其子公司提供作物生产力解决方案。它通过种子和综合产品、作物保护和作物营养三个部门运营。种子和综合产品部门提供种子特性、种质和种子处理包，以促进更健康和更高产的作物。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Bioceres Crop Solutions</li>
<li>How to Most Effectively Use the MarketBeat Earnings Screener</li>
<li>High-Flyers Near Resistance: 3 Stocks to Watch for a Dip</li>
<li>How to Invest in Blue Chip Stocks</li>
<li>Seagate Technology Leads S&amp;P 500: What’s Behind Its 120% Gain?</li>
<li>Stock Average Calculator</li>
<li>Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Bioceres Crop Solutions</li>
<li>如何最有效地使用 MarketBeat 收益筛选器</li>
<li>接近阻力的高飞股票：3 只值得关注的股票</li>
<li>如何投资蓝筹股</li>
<li>希捷科技引领标准普尔 500：其 120% 涨幅背后的原因是什么？</li>
<li>股票平均计算器</li>
<li>先锋集团的 VUG ETF：您投资组合的终极增长 ETF</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QklPWA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx?Prefix=NASDAQ&amp;Symbol=BIOX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Bioceres Crop Solutions Right Now?</h2>
<div class="lb-trans"><h2>您现在应该投资$1,000 于 Bioceres Crop Solutions 吗？</h2>
</div><p>Before you consider Bioceres Crop Solutions, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑 Bioceres Crop Solutions 之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bioceres Crop Solutions wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Bioceres Crop Solutions 并不在名单上。</p>
</div><p>While Bioceres Crop Solutions currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Bioceres Crop Solutions 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

Brookline Capital Management 调低了 BIOX 2026 财年的每股收益预期